Catalytic Wealth RIA LLC Acquires 6,553 Shares of Koninklijke Philips (NYSE:PHG)

Catalytic Wealth RIA LLC lifted its holdings in Koninklijke Philips (NYSE:PHG) by 42.1% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 22,124 shares of the technology company’s stock after purchasing an additional 6,553 shares during the quarter. Catalytic Wealth RIA LLC’s holdings in Koninklijke Philips were worth $442,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. Principal Securities Inc. bought a new stake in shares of Koninklijke Philips in the fourth quarter worth $27,000. Allspring Global Investments Holdings LLC bought a new stake in Koninklijke Philips during the first quarter worth $40,000. Fifth Third Bancorp raised its position in Koninklijke Philips by 34.4% during the first quarter. Fifth Third Bancorp now owns 3,008 shares of the technology company’s stock worth $60,000 after acquiring an additional 770 shares in the last quarter. Headlands Technologies LLC bought a new stake in Koninklijke Philips during the first quarter worth $91,000. Finally, GAMMA Investing LLC bought a new stake in Koninklijke Philips during the fourth quarter worth $146,000. Institutional investors own 13.67% of the company’s stock.

Koninklijke Philips Price Performance

Koninklijke Philips stock traded up $0.57 during trading hours on Monday, reaching $26.44. 645,614 shares of the stock were exchanged, compared to its average volume of 1,046,111. The company has a market cap of $24.85 billion, a P/E ratio of -26.95, a price-to-earnings-growth ratio of 0.95 and a beta of 0.72. The company has a current ratio of 1.20, a quick ratio of 0.78 and a debt-to-equity ratio of 0.58. Koninklijke Philips has a twelve month low of $17.75 and a twelve month high of $29.44. The stock has a 50 day moving average of $26.40 and a two-hundred day moving average of $23.37.

Koninklijke Philips (NYSE:PHG) last announced its quarterly earnings data on Monday, April 29th. The technology company reported $0.28 earnings per share (EPS) for the quarter. The firm had revenue of $4.49 billion for the quarter. Koninklijke Philips had a negative net margin of 4.41% and a positive return on equity of 9.82%. Equities analysts expect that Koninklijke Philips will post 1.5 EPS for the current fiscal year.

Koninklijke Philips Cuts Dividend

The business also recently declared an annual dividend, which was paid on Thursday, May 9th. Stockholders of record on Friday, May 10th were paid a $0.9154 dividend. The ex-dividend date of this dividend was Thursday, May 9th. This represents a dividend yield of 3.5%. Koninklijke Philips’s payout ratio is currently -95.83%.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on PHG shares. Sanford C. Bernstein raised shares of Koninklijke Philips from a “market perform” rating to an “outperform” rating in a research report on Monday, May 13th. UBS Group upgraded shares of Koninklijke Philips from a “sell” rating to a “neutral” rating in a report on Tuesday, April 30th. BNP Paribas upgraded shares of Koninklijke Philips from an “underperform” rating to a “neutral” rating in a report on Tuesday, May 7th. StockNews.com upgraded shares of Koninklijke Philips from a “hold” rating to a “buy” rating in a report on Monday, July 15th. Finally, JPMorgan Chase & Co. upgraded shares of Koninklijke Philips from an “underweight” rating to a “neutral” rating in a report on Tuesday, April 30th. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold”.

Koninklijke Philips Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.